Meme stocks and potential short squeeze stocks have made investors rich this year but you have to find the next meme stock ...

It’s seldom a good idea to buy shares of a company just because you’re looking for a short squeeze. Though pursuing stocks ...

Sentiment is often a key theme of Senior V.P. of Strategy Todd Salamone's Monday Morning Outlook. This also applies to individual equities, where Senior Quantitative Analyst Rocky White compiles a ...

Lucid, Avis, Hims & Hers Health and Upstart are some of the most heavily shorted stocks right now. Here's a look at the top ten.

The combination of retail hype and heavy short interest creates a classic squeeze setup. With nearly 39.5 million shares sold short, any sharp upward move could force short sellers to cover, ...

Beyond Meat (NASDAQ:BYND) has surged in recent times, reigniting speculation of a short squeeze in the plant-based meat maker. Short interest on BYND was over 50% of the float as of Wednesday.

This latest round of short squeeze hype is picking up, with plant-based meat company Beyond Meat leading the charge. Beyond Meat's roughly 1,600% rally had nothing to do with a short squeeze and ...

Beyond Meat has become the topic of conversation among meme stock investors following its four-day trough-to-peak ascent from $0.52 per share on Oct. 16 to a pre-market high of $8.85 on Oct. 22.

Beyond Meat faces severe financial distress despite a recent debt-for-equity swap and meme-driven rally, with dilution risk and high short interest. BYND's fundamentals remain weak: negative cash flow ...

Short interest can help investors gauge sentiment. Not only can high short interest identify potential high risks, it can also be a sign of a possible short squeeze situation – especially if the stock ...

We recently published 10 of Wall Street’s Outperformers. Clover Health Investments, Corp. (NASDAQ:CLOV) is one of the top-performing stocks last week. Clover Health saw its share prices soar by 40.96 ...

Clover Health Investments, Corp. (CLOV) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful ...